Get to Know EktaH: New therapeutic solutions to combat overweight and obesity

​Get to Know EktaH: New therapeutic solutions to combat overweight and obesity

​EktaH, founded in 2021 from the University of Bourgogne's Nutrition and Toxicology Department, leverages 15+ years of lipid metabolism research. The company develops therapies targeting fat taste receptors to improve hormonal regulation, addressing obesity's root causes and promoting healthier eating habits.

​This session is tailored for doctors, researchers, investors, and healthcare enthusiasts, offering a deep dive into EktaH's innovative approach to obesity treatment and its potential to reshape metabolic health.

​Explore the details: https://capitalcell.com/en/campaign/ektah/

​What will we cover in these sessions?

• ​What is EktaH?

​Discover the team behind EktaH, their mission, current progress, and future plans.

• ​Why is this project so relevant?

​Professor Naim Khan, Chief Scientific Officer at EktaH, and Xavier Boidevezi, CEO and former marketing expert at Danone and SEB, bring a powerful blend of scientific innovation and strategic vision. Professor Khan, a renowned researcher at the University of Bourgogne and recipient of the 2020 Academy of Medicine award for his pioneering work on lipid taste receptors, drives EktaH’s cutting-edge science. Xavier Boidevezi, with over a decade of experience in global brand strategy, ensures a clear path from lab to market. Together, they will present EktaH’s groundbreaking approach to obesity treatment and answer your questions, showcasing the science and strategy behind their innovation.

• ​Q&A Session

​Get answers to your questions about Capital Cell, how it works, and how you can be part of this journey.

​Spread the Word

​Share this webinar with your network to help advance the future of tissue transplants. See you soon!